Results 221 to 230 of about 15,081,754 (391)
A Mixed Approach to Rigorous Development of Control Designs
Butler, Michael+4 more
core +1 more source
Stemness properties, including quiescence, self‐renewal, and chemoresistance, are closely associated with leukemia relapse. Here, we demonstrate that DNA damage‐inducible transcript 4 (DDIT4) is induced in the hypoxic bone marrow niche and is essential for maintaining the stemness of AML1‐ETO9a leukemia cells.
Yishuang Li+12 more
wiley +1 more source
Parallel hybrid propulsion system with integration of designed electric machine for medium altitude long endurance UAV. [PDF]
Kurt E+3 more
europepmc +1 more source
Cost effective combined axial fan and throttling valve control of ventilation rate [PDF]
C. James Taylor+5 more
openalex +1 more source
Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi+12 more
wiley +1 more source
Output speed control for hydro-mechanical continuously variable transmission of tractor. [PDF]
Xi Z, Luo Z, Cao F, Niu L, Xu L.
europepmc +1 more source
Control of Integrated Powertrain With Electronic Throttle and Automatic Transmission [PDF]
Daekyun Kim+3 more
openalex +1 more source
Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs
In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza+3 more
wiley +1 more source
Experimental assessment of using phase change materials in vapor compression refrigeration systems for condenser pre-cooling. [PDF]
Riahi A, Shafii MB.
europepmc +1 more source
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh+5 more
wiley +1 more source